智通港股股东权益披露|10月6日

Group 1 - The latest shareholder equity disclosure for Lion Rock Group (01127) and CSPC Pharmaceutical Group (01093) was conducted on October 6, 2025 [1] - Liu Zhujian increased his holdings in Lion Rock Group from 360 million shares to 362 million shares, representing a holding percentage increase from 46.70% to 46.99% [2] - Cai Dongchen slightly increased his holdings in CSPC Pharmaceutical Group from 2.834 billion shares to 2.835 billion shares, with a holding percentage increase from 24.59% to 24.61% [2]